NCT02415088

Brief Summary

This is a randomised, observer-blinded trial to compare selective shoulder block with interscalene block. Both blocks will be placed using an ultra-sound guided technique. Primary outcome measures will be postoperative pain scores and use of rescue opioids. Secondary outcome measures will be pre- and postoperative occurence of motor deficit of the arm and dyspnea, quality of sleep in the first night after surgery as measured by a numeric rating scale and overall satisfaction with pain therapy as measured by the International Pain Outcomes questionnaire and an NRS-score (0 = not satisfied at all and 10 = very satisfied). Primary and secondary outcome measures will be assessed during the first 24hours after surgery (assessment in the postanesthetic care unit (PACU) directly after admission and before discharge and in the surgical ward at 4, 8 and 24 hours after surgery). Overall satisfaction with pain therapy will be assessed 48hours after surgery. An interscalene block is a block of the plexus brachialis in the interscelene triangle (by injecting a local anesthetic around the nerve plexus). A selective shoulder block is a block of the suprascapular and axillary nerves (by injecting a local anesthetic around these nerves).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2015

Completed
24 days until next milestone

Study Start

First participant enrolled

April 1, 2015

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 14, 2015

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
Last Updated

April 5, 2016

Status Verified

April 1, 2016

Enrollment Period

10 months

First QC Date

March 8, 2015

Last Update Submit

April 2, 2016

Conditions

Keywords

Nerve block

Outcome Measures

Primary Outcomes (2)

  • Pain Score as measured by Numeric Rating Scale

    24hours

  • Use of piritramide as documented by the PCIA (patient controlled intravenous analgesia) system

    24hours

Secondary Outcomes (4)

  • Subjective feeling of dyspnea as measured by a numeric rating scale

    24hours

  • Motor deficit after nerve block as measured by Medical Research Council scale

    24hours

  • Quality of sleep in the first night after surgery as measured by a numeric rating scale

    24hours

  • Overall satisfaction as measured by the International Pain Outcomes questionnaire

    48 hours

Study Arms (2)

Interscalene block

ACTIVE COMPARATOR

block of the plexus brachialis in the interscalene region with local anaesthetics

Procedure: Interscalene block

Selective shoulder block

ACTIVE COMPARATOR

selective block of the suprascapular nerve and the axillary nerve with local anaesthetics

Procedure: Selective shoulder block

Interventions

block of the plexus brachialis in the interscalene region with local anaesthetics

Interscalene block

selective block of the suprascapular nerve and the axillary nerve with local anaesthetics

Selective shoulder block

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective arthroscopic shoulder surgery
  • elective hospital admission for one night
  • age \> 18 years and \< 75 years
  • American Society of Anesthesiologists (ASA) physical status classification 1, 2 of 3.

You may not qualify if:

  • pregnancy
  • severe obesity ( BMI \> 35)
  • severe COPD (Gold≥ 3) or restrictive (FEV1 \< 50%) lungdisease
  • coagulation disorders
  • diabetes mellitus
  • previous injury or surgery of the involved shoulder
  • pre-existing neuropathy or myopathy of the involved arm
  • allergy or contra-indication for the medication used in the study
  • preoperative use of opioids
  • infection at the puncture site
  • inability to understand or speak Dutch
  • inability to understand the PCIA system
  • inability to understand the NRS pain score system
  • refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jessaziekenhuis Hasselt

Hasselt, Limburg, 3500, Belgium

Location

Related Publications (1)

  • Neuts A, Stessel B, Wouters PF, Dierickx C, Cools W, Ory JP, Dubois J, Jamaer L, Arijs I, Schoorens D. Selective Suprascapular and Axillary Nerve Block Versus Interscalene Plexus Block for Pain Control After Arthroscopic Shoulder Surgery: A Noninferiority Randomized Parallel-Controlled Clinical Trial. Reg Anesth Pain Med. 2018 Oct;43(7):738-744. doi: 10.1097/AAP.0000000000000777.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Dirk Schoorens, MD

    Jessa Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 8, 2015

First Posted

April 14, 2015

Study Start

April 1, 2015

Primary Completion

February 1, 2016

Study Completion

February 1, 2016

Last Updated

April 5, 2016

Record last verified: 2016-04

Locations